查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827796

2025年全球植入市場報告

Bio-Implants Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，植入市場規模強勁成長，從2024年的1,254.8億美元增加至2025年的1,369.6億美元，複合年成長率達9.1%。這段歷史時期的成長歸因於人口老化、慢性病增加、外科手術增多、預期壽命延長以及監管支持和標準。

預計未來幾年植入市場將快速成長，到2029年將達到2,073.3億美元，複合年成長率為10.9%。預測期內的成長歸因於客製化和個人化、微創手術的興起、向再生醫學、遠端監控和遠端醫療的轉變，以及有利的法規環境。預測期內的主要趨勢包括客製化和個人化植入、可生物分解和生物可吸收植入、生物材料、再生醫學和組織工程的進步、智慧植入以及穿戴式技術。

植入是由人體或動物性材料以及生物合成材料製成的先進醫療設備或假體器官。這些植入發揮重要作用，例如替換缺失組織、支撐受損生物結構以及最終增強人體的生物功能。植入有助於輔助和調節人體的各種生理功能。

植入包括幾種主要類型，包括心血管植入、人工植牙、脊椎植入、整形外科植入和眼科植入。心血管植入（例如心臟瓣膜和冠狀動脈支架）在治療心臟併發症方面發揮重要作用，旨在留在患者體內並支持健康的血管和正常的心臟功能。植入由各種材料製成，包括金屬、陶瓷、聚合物和生物成分。它們來自各種來源，包括同種異體移植、自體移植、異質骨移植和合成材料。這些植入應用於各種醫療保健環境，包括門診手術中心、診所、醫院和其他最終用戶設施。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供植入市場統計數據，包括全球植入市場規模、各地區市場佔有率、植入的市場佔有率、詳細的植入細分市場、市場趨勢和商業機會，以及您在植入行業取得成功所需的數據。本植入市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的全方位觀點。

未來五年的預測成長率為10.9%，較我們先前對該市場的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。這項影響將直接影響美國，因為義大利和瑞典的醫用級鈦和生物相容性塗層供應受限，這可能會推遲整形外科和牙科植入手術，並增加患者的費用。由於互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響，這一影響也將更加廣泛地顯現。

預計未來幾年，慢性病盛行率的上升將推動植入市場的成長。慢性病，包括心血管疾病和關節炎，指持續時間超過一年、需要持續治療且限制日常活動的疾病。植入在管理和監測此類慢性病方面發揮關鍵作用，有助於降低與此類疾病相關的死亡率。例如，2024 年 7 月，澳洲健康與福利研究所報告稱，慢性阻塞性肺病) 將成為 2022 年澳洲的主要死因，造成 7,691 人死亡，即每 100,000 人口中有 29.6 人死亡，佔所有死亡人數的 4.0%。因此，慢性病盛行率的上升正在推動植入市場的成長。

隨著高齡化社會的到來，老年人口比例不斷增加，植入市場也隨之成長。植入透過各種應用解決與老齡化相關的健康問題，包括即時健康監測、藥物傳遞和組織再生。根據世界衛生組織 (WHO) 2022 年 10 月發布的預測，到 2030 年，全球六分之一的人預計將年滿 60 歲或以上，這標誌著人口結構的重大變化。這種人口結構變化，即 60 歲及以上人口數量從 2020 年的 10 億增加到 14 億，清楚地表明了對植入的需求不斷成長。到 2050 年，全球 60 歲及以上人口預計將加倍，達到 21 億。人口老化是植入市場擴張的主要驅動力。

技術進步是植入市場的前沿，主要參與者專注於創新的生物材料技術，尤其是用於植入系統的3D列印技術。與傳統的金屬和聚合物不同，這種積層製造利用細胞和生物材料來創建3D結構。一個值得注意的例子是贏創工業股份公司於2022年3月推出的骨傳導性VESTAKEEP iC4800 3DF PEEK長絲。這種高性能聚合物基於3D列印技術，可促進骨骼與植入之間的骨整合，加速骨癒合。其顯著特性包括優異的生物相容性、生物穩定性和增強的骨傳導性，體現了植入領域技術創新的前沿。

植入市場包括商用支架、心律調節裝置、生物製藥、創傷植入、運動醫學、胸腔植入、椎間間隔器、機械加工同種異體移植間隔器、運動保護植入。此市場的價值是指“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球植入：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球植入市場：成長率分析
  • 全球植入市場表現：規模與成長，2019-2024
  • 全球植入市場預測：2024-2029年及2034年規模與成長
  • 全球植入：總目標市場（TAM）

第6章 市場細分

  • 全球植入市場：依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 心血管植入
  • 人工植牙
  • 脊椎植入
  • 整形外科植入
  • 眼科植入
  • 其他類型
  • 全球植入市場：按材料、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 金屬
  • 陶瓷製品
  • 聚合物
  • 生物
  • 全球植入市場（按來源、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 同種異體移植
  • 自體移植
  • 異種移植
  • 合成
  • 全球植入市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 門診手術中心
  • 診所
  • 醫院
  • 其他最終用戶
  • 全球植入市場：心血管植入的細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 支架
  • 心臟瓣膜
  • 心律調節器
  • 全球植入市場：依人工植牙類型細分，實際狀況及預測，2019-2024 年、2024-2029 年、2034 年
  • 骨內植入
  • 骨膜下植入
  • 顴骨植入
  • 全球植入市場：脊椎生物植入物的植入（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 脊椎固定器
  • 椎間盤
  • 脊椎棒和板
  • 全球植入市場：整形外科植入細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 關節重建植入
  • 骨折固定裝置
  • 接骨板和螺絲
  • 全球植入市場：眼科植入細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 人工水晶體（IOL）
  • 視網膜植入
  • 角膜植入
  • 全球植入市場：按類型、其他、實際和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 人工電子耳
  • 組織工程植入
  • 生物材料支架

第7章 區域和國家分析

  • 全球植入市場：區域表現及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球植入市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 植入市場：競爭格局
  • 植入市場：公司簡介
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Dentsply Sirona Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Arthrex Inc.
  • Boston Scientific Corporation
  • Smith & Nephew PLC
  • B. Braun Melsungen AG
  • Victrex PLC
  • Straumann Holding AG
  • Danaher Corporation
  • Cardinal Health Inc.
  • Organogenesis Holdings Inc.
  • Exactech Inc.
  • Osprey Medical Inc.
  • Edwards Lifesciences Corporation
  • Biotronik SE & Co. KG
  • aap Implantate AG
  • Abbott Laboratories

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年植入市場：提供新機會的國家
  • 2029年植入市場：細分領域帶來新機會
  • 2029年植入市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r22422u

Bio-implants are sophisticated medical devices or prostheses crafted from materials sourced from human or animal origin, as well as biosynthetic materials. These implants serve the crucial function of replacing missing tissues and supporting damaged biological structures, ultimately enhancing the body's biological functions. Bio-implants are instrumental in assisting and regulating various human physiological functions.

Within the bio-implant category, there are several main types, including cardiovascular implants, dental implants, spinal bio-implants, orthopedic implants, ophthalmic implants, and others. Cardiovascular implants, such as heart valves and coronary stents, play a vital role in treating cardiac complications, designed to remain within a patient's body to support healthy blood arteries and a functioning heart. Bio-implants are crafted from diverse materials, including metallic, ceramic, polymer, and biological components. They originate from different sources such as allograft, autograft, xenograft, and synthetic materials. These bio-implants find application in various healthcare settings, including ambulatory surgical centers, clinics, hospitals, and other end-user facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The bio-implants market research report is one of a series of new reports from The Business Research Company that provides bio-implants market statistics, including bio-implants industry global market size, regional shares, competitors with a bio-implants market share, detailed bio-implants market segments, market trends and opportunities, and any further data you may need to thrive in the bio-implants industry. This bio-implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bio-implants market size has grown strongly in recent years. It will grow from $125.48 billion in 2024 to $136.96 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to aging population and chronic diseases, rise in surgical procedures, increased life expectancy, regulatory support and standards.

The bio-implants market size is expected to see rapid growth in the next few years. It will grow to $207.33 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to customization and personalization, growth in minimally invasive procedures, shift towards regenerative medicine, remote monitoring and telemedicine, supportive regulatory environment. Major trends in the forecast period include customized and personalized implants, biodegradable and bioresorbable implants, advancements in biomaterials, regenerative medicine and tissue engineering, smart implants and wearable technologies.

The forecast of 10.9% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply constraints for medical-grade titanium and biocompatible coatings from Italy and Sweden, which could delay orthopedic and dental implant procedures while raising costs for patients.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic conditions is anticipated to drive growth in the bio-implant market in the coming years. Chronic conditions, including cardiovascular diseases and arthritis, are defined as medical issues that persist for a year or longer, necessitate ongoing medical care, and limit daily activities. Bio-implants play a crucial role in managing and monitoring these chronic conditions, contributing to a reduction in mortality rates associated with such diseases. For instance, in July 2024, the Australian Institute of Health and Welfare reported that chronic obstructive pulmonary disease (COPD) was responsible for 7,691 deaths in Australia in 2022, equating to 29.6 deaths per 100,000 people and accounting for 4.0% of all fatalities. Therefore, the increasing prevalence of chronic conditions is propelling the growth of the bio-implant market.

The bio-implants market is experiencing growth attributed to the aging population, characterized by an increasing proportion of elderly individuals in societies. Bio implants serve diverse purposes, including real-time health monitoring, drug delivery, and tissue regeneration, catering to age-related health issues. The World Health Organization's October 2022 projections indicate a significant demographic shift, with one in six individuals globally expected to be 60 years or older by 2030. This demographic transition, marked by a rise from 1 billion in 2020 to 1.4 billion individuals aged 60 and over, is a clear indication of the increasing demand for bio-implants. Looking ahead to 2050, the global population of individuals aged 60 and older is projected to double to 2.1 billion. The aging population is thus a significant driver for the expanding bio-implants market.

In the bio-implant market, key trends are centered around technological advancements, with major players focusing on innovative biomaterial technology, particularly 3D printing for bio-implant systems. This additive manufacturing technique produces 3D structures using cells and biomaterials, deviating from traditional metals and polymers. A notable example is the March 2022 launch of Evonik Industries AG's osteoconductive VESTAKEEP iC4800 3DF PEEK filament. This high-performance polymer, based on 3D-printing technology, enhances osteointegration between bone and implant, expediting bone healing. Notable features include impressive biocompatibility, biostability, and enhanced osteoconductive qualities, reflecting the forefront of technical innovation in the bio-implant sector.

Major companies in the bio-implants market are actively introducing novel implant solutions to elevate patient care standards. Notably, the introduction of the REGENETEN Bioinductive Implant by Smith+Nephew in July 2023 stands out. This collagen-based implant supports the body's natural healing response, fostering the growth of new tendon-like tissue to reinforce existing tendons. Launched in India after completing over 100,000 global procedures, this arthroscopically delivered implant has demonstrated promising results in rotator cuff disease. Clinical trials have shown an 86% relative reduction in re-tear rates at 12 months compared to conventional surgery alone, positioning the REGENETEN Bioinductive Implant as a transformative advancement in bio-implant technology.

In August 2022, CONMED Corporation, a prominent US-based medical technology company, made a strategic move by acquiring Biorez Inc., a medical device start-up, for an undisclosed amount. This acquisition is poised to enhance CONMED's sports medicine portfolio, with the addition of Biorez bringing innovative capabilities to the forefront. The acquisition strategically positions CONMED to capitalize on emerging technologies and reinforces its commitment to growth and innovation in the competitive bio-implant market.

Major companies operating in the bio-implants market are Medtronic PLC, Stryker Corporation, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., Johnson & Johnson, Arthrex Inc., Boston Scientific Corporation, Smith & Nephew PLC, B. Braun Melsungen AG, Victrex PLC, Straumann Holding AG, Danaher Corporation, Cardinal Health Inc., Organogenesis Holdings Inc., Exactech Inc., Osprey Medical Inc., Edwards Lifesciences Corporation, Biotronik SE & Co. KG, aap Implantate AG, Abbott Laboratories, Biotronik Inc., Cook Medical LLC, Globus Medical Inc., Integra LifeSciences Holdings Corporation, LivaNova PLC, MicroPort Scientific Corporation, NuVasive Inc., Orthofix Medical Inc., RTI Surgical Holdings Inc., Terumo Corporation

North America was the largest region in the bio-implants market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bio-implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bio-implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bio implants market consists of sales stents, pacing devices, orthobiologics, trauma implants, sport medicines, thoracolumber implants, intervertebral spacers, machined allograft spacers, and motion preservation implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bio-Implants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bio-implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bio-implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bio-implants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Cardiovascular Implants; Dental Implants; Spinal Bio-Implants; Orthopedic Implants; Ophthalmic Implants; Other Types
  • 2) By Material: Metallic; Ceramic; Polymer; Biological
  • 3) By Origin: Allograft; Autograft; Xenograft; Synthetic
  • 4) By End-User: Ambulatory Surgical Centers; Clinics; Hospital; Other End-Users
  • Subsegments:
  • 1) By Cardiovascular Implants: Stents; Heart Valves; Pacemakers
  • 2) By Dental Implants: Endosteal Implants; Subperiosteal Implants; Zygomatic Implants
  • 3) By Spinal Bio-Implants: Spinal Fusion Devices; Intervertebral Discs; Spinal Rods And Plates
  • 4) By Orthopedic Implants: Joint Replacement Implants; Fracture Fixation Devices; Bone Plates And Screws
  • 5) By Ophthalmic Implants: Intraocular Lenses (IOLs); Retinal Implants; Corneal Implants
  • 6) By Other Types: Cochlear Implants; Tissue Engineering Implants; Biomaterial Scaffolds
  • Companies Mentioned: Medtronic PLC; Stryker Corporation; Zimmer Biomet Holdings Inc.; Dentsply Sirona Inc.; Johnson & Johnson; Arthrex Inc.; Boston Scientific Corporation; Smith & Nephew PLC; B. Braun Melsungen AG; Victrex PLC; Straumann Holding AG; Danaher Corporation; Cardinal Health Inc.; Organogenesis Holdings Inc.; Exactech Inc.; Osprey Medical Inc.; Edwards Lifesciences Corporation; Biotronik SE & Co. KG; aap Implantate AG; Abbott Laboratories; Biotronik Inc.; Cook Medical LLC; Globus Medical Inc.; Integra LifeSciences Holdings Corporation; LivaNova PLC; MicroPort Scientific Corporation; NuVasive Inc.; Orthofix Medical Inc.; RTI Surgical Holdings Inc.; Terumo Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bio-Implants Market Characteristics

3. Bio-Implants Market Trends And Strategies

4. Bio-Implants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Bio-Implants Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Bio-Implants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Bio-Implants Market Growth Rate Analysis
  • 5.4. Global Bio-Implants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Bio-Implants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Bio-Implants Total Addressable Market (TAM)

6. Bio-Implants Market Segmentation

  • 6.1. Global Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Implants
  • Dental Implants
  • Spinal Bio-Implants
  • Orthopaedic Implants
  • Ophthalmic Implants
  • Other Types
  • 6.2. Global Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metallic
  • Ceramic
  • Polymer
  • Biological
  • 6.3. Global Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Allograft
  • Autograft
  • Xenograft
  • Synthetic
  • 6.4. Global Bio-Implants Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ambulatory Surgical Centers
  • Clinics
  • Hospital
  • Other End-Users
  • 6.5. Global Bio-Implants Market, Sub-Segmentation Of Cardiovascular Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stents
  • Heart Valves
  • Pacemakers
  • 6.6. Global Bio-Implants Market, Sub-Segmentation Of Dental Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endosteal Implants
  • Subperiosteal Implants
  • Zygomatic Implants
  • 6.7. Global Bio-Implants Market, Sub-Segmentation Of Spinal Bio-Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinal Fusion Devices
  • Intervertebral Discs
  • Spinal Rods And Plates
  • 6.8. Global Bio-Implants Market, Sub-Segmentation Of Orthopedic Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Joint Replacement Implants
  • Fracture Fixation Devices
  • Bone Plates And Screws
  • 6.9. Global Bio-Implants Market, Sub-Segmentation Of Ophthalmic Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intraocular Lenses (IOLs)
  • Retinal Implants
  • Corneal Implants
  • 6.10. Global Bio-Implants Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cochlear Implants
  • Tissue Engineering Implants
  • Biomaterial Scaffolds

7. Bio-Implants Market Regional And Country Analysis

  • 7.1. Global Bio-Implants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Bio-Implants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bio-Implants Market

  • 8.1. Asia-Pacific Bio-Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bio-Implants Market

  • 9.1. China Bio-Implants Market Overview
  • 9.2. China Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bio-Implants Market

  • 10.1. India Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bio-Implants Market

  • 11.1. Japan Bio-Implants Market Overview
  • 11.2. Japan Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bio-Implants Market

  • 12.1. Australia Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bio-Implants Market

  • 13.1. Indonesia Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bio-Implants Market

  • 14.1. South Korea Bio-Implants Market Overview
  • 14.2. South Korea Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bio-Implants Market

  • 15.1. Western Europe Bio-Implants Market Overview
  • 15.2. Western Europe Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bio-Implants Market

  • 16.1. UK Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bio-Implants Market

  • 17.1. Germany Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bio-Implants Market

  • 18.1. France Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bio-Implants Market

  • 19.1. Italy Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bio-Implants Market

  • 20.1. Spain Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bio-Implants Market

  • 21.1. Eastern Europe Bio-Implants Market Overview
  • 21.2. Eastern Europe Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bio-Implants Market

  • 22.1. Russia Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bio-Implants Market

  • 23.1. North America Bio-Implants Market Overview
  • 23.2. North America Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bio-Implants Market

  • 24.1. USA Bio-Implants Market Overview
  • 24.2. USA Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bio-Implants Market

  • 25.1. Canada Bio-Implants Market Overview
  • 25.2. Canada Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bio-Implants Market

  • 26.1. South America Bio-Implants Market Overview
  • 26.2. South America Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bio-Implants Market

  • 27.1. Brazil Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bio-Implants Market

  • 28.1. Middle East Bio-Implants Market Overview
  • 28.2. Middle East Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bio-Implants Market

  • 29.1. Africa Bio-Implants Market Overview
  • 29.2. Africa Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bio-Implants Market Competitive Landscape And Company Profiles

  • 30.1. Bio-Implants Market Competitive Landscape
  • 30.2. Bio-Implants Market Company Profiles
    • 30.2.1. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Dentsply Sirona Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

31. Bio-Implants Market Other Major And Innovative Companies

  • 31.1. Arthrex Inc.
  • 31.2. Boston Scientific Corporation
  • 31.3. Smith & Nephew PLC
  • 31.4. B. Braun Melsungen AG
  • 31.5. Victrex PLC
  • 31.6. Straumann Holding AG
  • 31.7. Danaher Corporation
  • 31.8. Cardinal Health Inc.
  • 31.9. Organogenesis Holdings Inc.
  • 31.10. Exactech Inc.
  • 31.11. Osprey Medical Inc.
  • 31.12. Edwards Lifesciences Corporation
  • 31.13. Biotronik SE & Co. KG
  • 31.14. aap Implantate AG
  • 31.15. Abbott Laboratories

32. Global Bio-Implants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bio-Implants Market

34. Recent Developments In The Bio-Implants Market

35. Bio-Implants Market High Potential Countries, Segments and Strategies

  • 35.1 Bio-Implants Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Bio-Implants Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Bio-Implants Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer